一项多中心II期研究评估了亚洲患有良性大脑缩症患者的博图拉克斯的安全性和有效性
Ji Su Lee1, Hyung Seok Son1, Beom Joon Kim2
1From the Department of Dermatology, Konkuk University School of Medicine.
Plastic and reconstructive surgery
|June 19, 2023
概括
甲型玻尿素毒素 (BTA) 有效地减少了良性肌肉缩 (BMH) 的肌肉厚度. 48U或更高的剂量提供了具有成本效益的治疗,副作用最小.
科学领域:
- 整形外科 整形外科 整形外科
- 皮肤病学 皮肤病学
- 化品医学 化品医学
背景情况:
- 良性麻氏体缩 (BMH) 由于增加了麻氏体肌肉厚度,导致下线突出.
- 毒素A型 (BTA) 是一种潜在的治疗方法,但最佳剂量仍在争论中.
研究的目的:
- 为了确定BTA治疗BMH的有效剂量.
- 评估BTA在BMH治疗中的有效性和患者满意度.
主要方法:
- 80名患有BMH的成年患者随机分为安慰剂和BTA组 (24 U, 48 U, 72 U, 96 U).
- 在12周内,通过超声波,3D面部分析,视觉评估和患者满意度来评估治疗有效性.
主要成果:
- 与安慰剂相比,所有BTA剂量都显著降低了按摩器肌肉厚度.
- 肌肉厚度的减少在12周内从-2.33毫米 (24U) 到-3.79毫米 (96U) 之间.
- 与安慰剂相比,BTA组 (除4周24个单位) 的患者满意度更高,没有显著的不良事件.
结论:
- 建议BTA剂量至少为48U用于BMH治疗.
- 这种剂量具有成本效益,并与副作用的风险较低有关.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
711
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
711
Skeletal Muscle Relaxants: Therapeutic Uses
521
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
521
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.4K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.4K
Centrally Acting Muscle Relaxants: Therapeutic Uses
746
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
746


